Sexual AddictionPAS-CDNCT05483426
Prevalence of Sexual Addiction in an Inmate Population at the Muret Detention Center in Haute-Garonne (PAS-CD)
A study testing semi-structured Interviews in people with Sexual Addiction, run by Federation Regionale de Recherche en Psychiatrie et Sante Mentale Occitanie at 1 site in France.
Trial summary
Sexual addiction, also known as hypersexuality or compulsive sexuality, is a human sexual behavior that results in a continuous and persistent search for sexual pleasure. Replacing the former terms satyriasis and nymphomania, the World Health Organization (WHO) ICD-11 has referred to this disorder as "compulsive… Read more about this study
- Who is it for?
- Ages 18 to 65 years, men only
- Conditions the study is for
- Sexual Addiction
- What is being tested?
- semi-structured Interviews
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteFrance
- Study dates
- 26 Apr 2023to 26 Apr 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- Men only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Male subjects
- Detainees at Muret Detention Center
- Aged between 18 and 65 at the time of the search
- And having agreed to participate in the research.
Who cannot join
- Person under legal protection, guardianship or curatorship ;
- Insufficient command of the French language
- Existence of cognitive disorders preventing a good understanding of the information relating to the study or the various questionnaires.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
Julien DA COSTA
Toulouse, 31000
Julien JD Da Costa, MD, 05 61 14 90 10 ext. +33, julien.da-costa@ch-marchant.fr
Julien JD Da Costa, MD
About this study
Official title: Prevalence of Sexual Addiction in an Inmate Population at the Muret Detention Center in Haute-Garonne.
Sexual addiction, also known as hypersexuality or compulsive sexuality, is a human sexual behavior that results in a continuous and persistent search for sexual pleasure. Replacing the former terms satyriasis and nymphomania, the World Health Organization (WHO) ICD-11 has referred to this disorder as "compulsive sexual behavior disorders".
From multiple causes (iatrogeny, neurological causes, psychiatric causes, psychopathological hypotheses), but still only partially known, the inclusion of this disorder among impulsivity-related disorders, obsessive-compulsive disorders or addiction-related disorders is still debated in the scientific literature. Thus, in the absence of sufficient robust scientific data, DSM-5 refused to include this disorder in its classification.
Read more
However, the consequences of this disorder on the psychosocial functioning of individuals are not negligible, which can go as far as the precipitation of a transition to an heteroaggressive act which can thus lead to incarceration.
The prevalence of this disorder in the general population is estimated between 2 and 6% based on current literature data. This rate appears to be higher among men and more specifically among sex offenders.
However, some authors have noted that the difficulty in determining a clear prevalence of sexual addiction may be related to the still poorly defined diagnostic criteria for this disorder as well as the choice of measurement tools.
In the inmate population, to our knowledge, there are no French prevalence studies of this disorder. In addition, no studies have been conducted to compare the prevalence of sexual addiction among sex offenders (SASO) with that among non-sex offenders (SANSO).
We hope that better screening for addiction would enable better management of patients with this disorder, promoting their psychosocial rehabilitation and well-being, so as to prevent the recurrence of a transition to sexual arousal.
Read the detailed description
This study is intended to assess the prevalence of sexual addiction among a population of detainees at the Muret detention center in Haute-Garonne.
- Conditions
- Sexual Addiction
- Being tested
- semi-structured Interviews
- Medical subject headings
- Compulsive Sexual Behavior Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
semi-structured InterviewsOther
semi-structured interview conducted by a psychiatrist
| Study group | Role | What they receive |
|---|---|---|
| Interviews | Other | semi-directive interview Receives: Other: semi-structured Interviews |
What is being measured
The primary outcome is the main question the study is designed to answer.
The main objective is to determine the prevalence of sexual addiction among a population of men incarcerated at the Muret detention center in Haute-Garonne.
The primary endpoint is the presence of a patient's sexual addiction defined by a score greater than 13 on the Carnes screening test.
Measured: Day 1
Secondary outcomes (4)
Determine the prevalence of sexual addiction in a population of sexual offenders
The distribution of the proportions of people with sexual addiction is defined by a score greater than 13 on the Carnes screening test in two population groups, perpetrators of sexual offenses and perpetrators of non-sexual offenses.
Measured: Day 1
Determine the prevalence of sexual addiction in a population of non-sexual offenders
The distribution of the proportions of people with sexual addiction is defined by a score greater than 13 on the Carnes screening test in two population groups, perpetrators of sexual offenses and perpetrators of non-sexual offenses.
Measured: Day 1
Compare the prevalence of sexual addiction in these two populations
The distribution of the proportions of people with sexual addiction is defined by a score greater than 13 on the Carnes screening test in two population groups, perpetrators of sexual offenses and perpetrators of non-sexual offenses.
Measured: Day 1
Determine any addictive and psychiatric co-morbidities associated with each population
The presence of psychiatric disorders based on medical file and the addictive disorders based tanks ASSIST Test (Alcohol, Smoking and Substance Involvement Screening Test).
Measured: Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Aug 2022
- Study start26 Apr 2023
- Primary completion26 Apr 2027 (estimated)
- Study completion26 Apr 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Sexual AddictionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Federation Regionale de Recherche en Psychiatrie et Sante Mentale Occitanie
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05483426
- Sponsor's protocol ID
- 2022-A00342-41
- Acronym
- PAS-CD
- Status last verified
- Aug 2026
- First submitted
- 29 Jul 2022
- Last updated
- 2 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence of Sexual Addiction in an Inmate Population at the Muret Detention Center in Haute-Garonne.
- ClinicalTrials.gov ID
- NCT05483426
- Acronym / sponsor ID
- PAS-CD / 2022-A00342-41
- Conditions
- Sexual Addiction
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Federation Regionale de Recherche en Psychiatrie et Sante Mentale OccitanieUniversity, hospital or other
- Study start
- 26 Apr 2023 (actual)
- Primary completion
- 26 Apr 2027 (estimated)
- Study completion
- 26 Apr 2027 (estimated)
- First posted
- 2 Aug 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Sexual addiction, also known as hypersexuality or compulsive sexuality, is a human sexual behavior that results in a continuous and persistent search for sexual pleasure. Replacing the former terms satyriasis and nymphomania, the World Health Organization (WHO) ICD-11 has referred to this disorder as "compulsive sexual behavior disorders".
From multiple causes (iatrogeny, neurological causes, psychiatric causes, psychopathological hypotheses), but still only partially known, the inclusion of this disorder among impulsivity-related disorders, obsessive-compulsive disorders or addiction-related disorders is still debated in the scientific literature. Thus, in the absence of sufficient robust scientific data, DSM-5 refused to include this disorder in its classification.
However, the consequences of this disorder on the psychosocial functioning of individuals are not negligible, which can go as far as the precipitation of a transition to an heteroaggressive act which can thus lead to incarceration.
The prevalence of this disorder in the general population is estimated between 2 and 6% based on current literature data. This rate appears to be higher among men and more specifically among sex offenders.
However, some authors have noted that the difficulty in determining a clear prevalence of sexual addiction may be related to the still poorly defined diagnostic criteria for this disorder as well as the choice of measurement tools.
In the inmate population, to our knowledge, there are no French prevalence studies of this disorder. In addition, no studies have been conducted to compare the prevalence of sexual addiction among sex offenders (SASO) with that among non-sex offenders (SANSO).
We hope that better screening for addiction would enable better management of patients with this disorder, promoting their psychosocial rehabilitation and well-being, so as to prevent the recurrence of a transition to sexual arousal.
Detailed description
This study is intended to assess the prevalence of sexual addiction among a population of detainees at the Muret detention center in Haute-Garonne.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Interviews | Other | Other: semi-structured Interviewssemi-directive interview |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Male subjects
- Detainees at Muret Detention Center
- Aged between 18 and 65 at the time of the search
- And having agreed to participate in the research.
Key exclusion criteria (3 listed)
- Person under legal protection, guardianship or curatorship ;
- Insufficient command of the French language
- Existence of cognitive disorders preventing a good understanding of the information relating to the study or the various questionnaires.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| semi-structured Interviewssemi-structured interview conducted by a psychiatrist | Other | Interviews |
Primary outcome
The main objective is to determine the prevalence of sexual addiction among a population of men incarcerated at the Muret detention center in Haute-Garonne.
Time frame: Day 1
The primary endpoint is the presence of a patient's sexual addiction defined by a score greater than 13 on the Carnes screening test.
4 secondary outcomes
Determine the prevalence of sexual addiction in a population of sexual offenders
Time frame: Day 1
Determine the prevalence of sexual addiction in a population of non-sexual offenders
Time frame: Day 1
Compare the prevalence of sexual addiction in these two populations
Time frame: Day 1
Determine any addictive and psychiatric co-morbidities associated with each population
Time frame: Day 1
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Sep 2026.
- Individual participant dataSharing planned: No
Related trials for Sexual Addiction
Recruiting
The Trans-Led Care Study
Substance Abuse, Substance Addiction
Not yet recruiting
QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)
Asperger's Disorder, Asperger Disorder
Active, not recruiting
Evaluation of Effectiveness of the LifeSkills Training - Lombardia - Primary Shool Program ( Val3P-LST )
Well Being, Drug Addiction
RecruitingObservational study
Is Craving a Central Criterion for Diagnosing a Behavioral Addiction?
Addictive Behaviors, Internet Addiction Disorder
Active, not recruitingObservational study
Health Surveillance at Constructor University Bremen (CUB)
Social Isolation or Loneliness, Anxiety
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing semi-structured Interviews in people with Sexual Addiction, run by Federation Regionale de Recherche en Psychiatrie et Sante Mentale Occitanie at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 2 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Julien JD Da Costa, MD (05 61 14 90 10 ext. +33, julien.da-costa@ch-marchant.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The main objective is to determine the prevalence of sexual addiction among a population of men incarcerated at the Muret detention center in Haute-Garonne. (time frame: Day 1). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Sep 2026.